CLINICAL_TRIALS
trial_result
· 2017-09-19
Clinical Trial Update: Evolocumab Compared to LDL-C Apheresis in Patients Receiving LDL-C Apheresis Prior to Study Enrollment [Phase 3]
Summary
Phase 3 trial comparing evolocumab to LDL-C apheresis in patients already receiving apheresis; study completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Amgen | Conditions: Hypercholesterolemia | Phase 3 | Status: COMPLETED | Results posted: 2017-09-19